|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Yu Y, Lang Q, Chen Z, Li B, Yu C, Zhu D,
Zhai X and Ling C: The efficacy for unresectable hepatocellular
carcinoma may be improved by transcatheter arterial
chemoembolization in combination with a traditional Chinese herbal
medicine formula: a retrospective study. Cancer. 115:5132–5138.
2009. View Article : Google Scholar
|
|
3
|
Meng MB, Cui YL, Guan YS, Ying Z, Zheng
MH, Yuan CK and Zhang RM: Traditional Chinese medicine plus
transcatheter arterial chemoembolization for unresectable
hepatocellular carcinoma. J Altern Complement Med. 14:1027–1042.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shu X, McCulloch M, Xiao H, Broffman M and
Gao J: Chinese herbal medicine and chemotherapy in the treatment of
hepatocellular carcinoma: a meta-analysis of randomized controlled
trials. Integr Cancer Ther. 4:219–229. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Du Q, Hu B, Shen KP and An HM:
Pathogenesis and treatment law of Traditional Chinese Medicine in
hepatocarcinoma. World J Integr Tradit West Med. 5:814–817.
2010.(In Chinese).
|
|
6
|
Yan JG and Yao SK: The study of TCM
syndrome differentiation and treatment in liver cancer. Chin J
Integr Tradit West Med Liver Dis. 20:189–190. 2010.(In
Chinese).
|
|
7
|
Pan MQ and Tian H: Employ the methods of
invigorating spleen and regulating Qi, clearing toxic heat,
dissipating stasis and softening hardness to treat primary hepatic
cancer. J Tradit Chinese Med. 34:239–240. 1993.(In Chinese).
|
|
8
|
Li YL and Zhang SP: The effects of
invigorating spleen and regulating Qi in patients with primary
hepatic cancer: an analysis of 127 cases. Tianjin Tradit Chinese
Med. 17:12–13. 2000.(In Chinese).
|
|
9
|
Liu Q, Zhang YB, Ma CH, Yue XQ and Ling
CQ: Analysis of literature on therapeutic methods and medicines of
traditional Chinese medicine for primary liver cancer. Zhong Xi Yi
Jie He Xue Bao. 3:260–262. 2005.(In Chinese).
|
|
10
|
Bo X, Zhao XM, Liu HT, Ma WG and Li H: A
study on 4 kinds of Chinese medicines reducing arrest of bone
marrow by cyclophosphomidum. J Beijing Union Univ (Natural
Science). 8:58–61. 1994.(In Chinese).
|
|
11
|
Zhao YL and Fan WX: The effects of
Nü-zhen-zi formula on chemotherapy induced alopecia. Acta Univ Med
Nanjing (Natural Science). 24:305–306. 2004.(In Chinese).
|
|
12
|
Wu XF, Han SY, Zhu LS, Bai J and Liu SM:
The effects of Ligustrum lucidum Ait. fruits extract on
cyclophosphomidum induced immunosuppression. J North China Coal Med
Coll. 10:303–304. 2008.(In Chinese).
|
|
13
|
Shoemaker M, Hamilton B, Dairkee SH, Cohen
I and Campbell MJ: In vitro anticancer activity of twelve Chinese
medicinal herbs. Phytother Res. 19:649–651. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jeong JC, Kim JW, Kwon CH, Kim TH and Kim
YK: Fructus ligustri lucidi extracts induce human glioma
cell death through regulation of Akt/mTOR pathway in vitro and
reduce glioma tumor growth in U87MG xenograft mouse model.
Phytother Res. 25:429–434. 2011.
|
|
15
|
Zhang JF, He ML, Dong Qi, Xie WD, Chen YC,
Lin MC, Leung PC, Zhang YO and Kung HF: Aqueous extracts of Fructus
Ligustri Lucidi enhance the sensitivity of human colorectal
carcinoma DLD-1 cells to doxorubicin-induced apoptosis via Tbx3
suppression. Integr Cancer Ther. 10:85–91. 2011. View Article : Google Scholar
|
|
16
|
Hu B, An HM, Shen KP, Xu L, Du Q, Deng S
and Wu Y: Modified Yi Guan Jian, a Chinese herbal formula, induces
anoikis in Bel-7402 human hepatocarcinoma cells in vitro.
Oncol Rep. 26:1465–1470. 2011.PubMed/NCBI
|
|
17
|
Hu B, Shen KP, An HM, Wu Y and Du Q:
Aqueous extract of Curcuma aromatica induces apoptosis and
G2/M arrest in human colon carcinoma LS-174-T cells independent of
p53. Cancer Biother Radiopharm. 26:97–104. 2011.
|
|
18
|
Dimri GP, Lee X, Basile G, Acosta M, Scott
G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O,
Peacocke M and Campisi J: A biomarker that identifies senescent
human cells in culture and in aging skin in vivo. Proc Natl Acad
Sci USA. 92:9363–9367. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chiantore MV, Vannucchi S, Mangino G,
Percario ZA, Affabris E, Fiorucci G and Romeo G: Senescence and
cell death pathways and their role in cancer therapeutic outcome.
Curr Med Chem. 16:287–300. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Brown JM and Attardi LD: The role of
apoptosis in cancer development and treatment response. Nat Rev
Cancer. 5:231–237. 2005.PubMed/NCBI
|
|
21
|
Roninson IB: Tumor cell senescence in
cancer treatment. Cancer Res. 63:2705–2715. 2003.PubMed/NCBI
|
|
22
|
Dimri GP: What has senescence got to do
with cancer? Cancer Cell. 7:505–512. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Meier P and Vousden KH: Lucifer’s
labyrinth - ten years of path finding in cell death. Mol Cell.
28:746–754. 2007.
|
|
24
|
Schmitt CA: Cellular senescence and cancer
treatment. Biochim Biophys Acta. 1775:5–20. 2007.PubMed/NCBI
|
|
25
|
Gewirtz DA, Holt SE and Elmore LW:
Accelerated senescence: an emerging role in tumor cell response to
chemotherapy and radiation. Biochem Pharmacol. 76:947–957. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nardella C, Clohessy JG, Alimonti A and
Pandolfi PP: Pro-senescence therapy for cancer treatment. Nat Rev
Cancer. 11:503–511. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Di X, Shiu RP, Newsham IF and Gewirtz DA:
Apoptosis, autophagy, accelerated senescence and reactive oxygen in
the response of human breast tumor cells to adriamycin. Biochem
Pharmacol. 77:1139–1150. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
te Poele RH, Okorokov AL, Jardine L,
Cummings J and Joel SP: DNA damage is able to induce senescence in
tumor cells in vitro and in vivo. Cancer Res. 62:1876–1883.
2002.PubMed/NCBI
|
|
29
|
Han Z, Wei W, Dunaway S, Darnowski JW,
Calabresi P, Sedivy J, Hendrickson EA, Balan KV, Pantazis P and
Wyche JH: Role of p21 in apoptosis and senescence of human colon
cancer cells treated with camptothecin. J Biol Chem.
277:17154–17160. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kagawa S, Fujiwara T, Kadowaki Y, Fukazawa
T, Sok-Joo R, Roth JA and Tanaka N: Overexpression of the
p21sdi1 gene induces senescence-like state
in human cancer cells: implication for senescence-directed
molecular therapy for cancer. Cell Death Differ. 6:765–772.
1999.
|
|
31
|
Ahmad N, Adhami VM, Afaq F, Feyes DK and
Mukhtar H: Resveratrol causes WAF-1/p21-mediated
G1-phase arrest of cell cycle and induction of apoptosis
in human epidermoid carcinoma A431 cells. Clin Cancer Res.
7:1466–1473. 2001.PubMed/NCBI
|
|
32
|
Liu WK, Cheung FW, Liu BP, Li C, Ye W and
Che CT: Involvement of p21 and FasL in induction of cell cycle
arrest and apoptosis by neochamaejasmin A in human prostate LNCaP
cancer cells. J Nat Prod. 71:842–846. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Thaler S, Hähnel PS, Schad A, Dammann R
and Schuler M: RASSF1A mediates p21Cip1/Waf1-dependent
cell cycle arrest and senescence through modulation of the
Raf-MEK-ERK pathway and inhibition of Akt. Cancer Res.
69:1748–1757. 2009.PubMed/NCBI
|
|
34
|
Peng CC, Chen KC, Peng RY, Chyau CC, Su CH
and Hsieh-Li HM: Antrodia camphorata extract induces
replicative senescence in superficial TCC, and inhibits the
absolute migration capability in invasive bladder carcinoma cells.
J Ethnopharmacol. 109:93–103. 2007. View Article : Google Scholar
|
|
35
|
Wakoh T, Uekawa N, Terauchi K, Sugimoto M,
Ishigami A, Shimada J and Maruyama M: Implication of p53-dependent
cellular senescence related gene, TARSH in tumor suppression.
Biochem Biophys Res Commun. 380:807–812. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lodygin D, Menssen A and Hermeking H:
Induction of the Cdk inhibitor p21 by LY83583 inhibits tumor cell
proliferation in a p53-independent manner. J Clin Invest.
110:1717–1727. 2002. View Article : Google Scholar : PubMed/NCBI
|
